New Antiviral Influenza Treatment

New treatment for flu!

On October 24, 2018, the Food and Drug Administration (FDA) approved a new antiviral influenza treatment, Xofluza (baloxavir marboxil). It’s the first new antiviral flu treatment approved by the FDA in nearly 20 years. Since the current flu season has already started across the country and many people are expected to be affected, the timing of this new drug treatment could not be any better. It is a safe and effective treatment taken as a single oral dose. It is approved for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have had symptoms for no more than 48 hours. The most common side effects are diarrhea and bronchitis. It may reduce the duration of flu symptoms such as fever and muscle aches and theoretically reduce the incidence of complications such as pneumonia.

Current treatment options include Tamiflu (oseltamivir) and Relenza (zanamivir). Tamiflu is taken orally twice a day for 5 days and Relenza is an inhaled powder.
Although there are multiple treatment options for flu, there is no substitute for annual flu vaccine which is best taken by end of October.

Disclaimer: The information is intended to provide general education for patients and their families. The information provided does not constitute medical or health care advice for any individual and is not a substitute for medical and other professional advice and service.

You Might Also Enjoy...

Covid-19 Vaccines- Video

Sharing an educational video about COVID-19 vaccines – their safety & effectiveness and why we should get vaccinated to end this pandemic!

Covid-19 Vaccine Update – 3

COVID-19 Vaccine Update – 3 Yesterday the US Food and Drug Administration gave a new emergency use authorization (EUA) for a second vaccine against COVID-19.

Covid -19 Vaccine Update-2

Yesterday was a monumental day in the once-in-a-century pandemic that has killed nearly 300,000 American in less than one year. The Food and Drug Administration late last evening granted emergency authorization to Pfizer/BioNTech’s covid vaccine for...

Covid-19 Vaccine Update

COVID-19 VACCINE UPDATE The global threat from Covid-19 pandemic continues and the biopharmaceutical industry is working hard to develop a safe and effective vaccine.